Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Better U Care vs eMI Aesthetics

Better U Care
Graded #234

Lower grade

vs+5.5
eMI Aesthetics
Graded #104

Higher grade

The verdict

eMI Aesthetics takes it — 70.3/100 to 64.8/100.

eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueeMI Aesthetics +25
48
73
Dose & formulationBetter U Care +1
85
84
Clinical oversightBetter U Care +4
74
70
Labs & monitoringBetter U Care +1
52
51
FulfillmenteMI Aesthetics +4
73
77
Contract termsEven
55
55
Better U Care · left bareMI Aesthetics · right bar

The numbers

MetricBetter U CareeMI Aesthetics
WeighScore64.8/10070.3/100
GradeCC
Scorecard rank#234#104
Semaglutide$298/mo$179/mo (all doses, compounded)
Tirzepatide$397/moNot disclosed
Coverage21 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Better U Care

Graded #234 · C

Strengths

  • Transparent self-pay pricing with no insurance required
  • Offers both compounded and brand-name semaglutide and tirzepatide
  • Uniform compounded pricing across all doses with supplies included
  • Publishes its full list of covered states

Where it loses points

  • Available in 21 states rather than nationwide
  • Does not name a compounding pharmacy or list an accreditation seal
  • Brand medications carry a separate 150 dollar consult fee
eMI Aesthetics

Graded #104 · C

Strengths

  • Available to eligible patients in all 50 states
  • Offers both semaglutide and tirzepatide, plus an oral semaglutide option
  • Intake and provider visits run through OpenLoop Health, an established telehealth network

Where it loses points

  • Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
  • No fill pharmacy or named medical director is publicly listed
  • Support appears limited to email, with no phone number or hours published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard